Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01716663 · ClinicalTrials.gov registry record
CARTO® 3 System and Real Time Intracardiac Ultrasound
A clinical trial, sponsored by Biosense Webster.
- Completed
- Registry status
- 234
- Enrollment target
NCT01716663 is a clinical trial that has completed, run by Biosense Webster. The registered enrollment target is 234 participants.
The verdict
NCT01716663 has completed, sponsored by Biosense Webster.
- COMPLETED
- Registry status
- 234 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, non-randomized observational study of subjects 18 years and older undergoing RF ablation with drug refractory recurrent symptomatic paroxysmal Atrial Fibrillation (AF).
Interventions
- DEVICE Catheter Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01716663
The ClinicalTrials.gov registry entry for NCT01716663 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biosense Webster, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Catheter Ablation is the first listed.
NCT01716663 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01716663 about?
NCT01716663 is a clinical study titled "CARTO® 3 System and Real Time Intracardiac Ultrasound". This is a prospective, multicenter, non-randomized observational study of subjects 18 years and older undergoing RF ablation with drug refractory recurrent symptomatic paroxysmal Atrial Fibrillation (AF).
What is the current status of trial NCT01716663?
This trial is currently completed. The enrollment target is 234 participants. The study started on 2012-10. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01716663?
The interventions under investigation include: Catheter Ablation (DEVICE).
Who is sponsoring clinical trial NCT01716663?
This trial is sponsored by Biosense Webster, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.